Tryp Therapeutics Financials

Tryp Therapeutics Stock Summary

Tryp Therapeutics competes with Pharmather Holdings, SanBio Company, Sosei Group, Antibe Therapeutics, and Cellectis. Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company was incorporated in 2019 and is based in Kelowna, Canada. Tryp Thrapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Tryp Therapeutics Key Financial Ratios

There are many critical financial ratios that Tryp Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Tryp Therapeutics reports annually and quarterly.

Tryp Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tryp Therapeutics's current stock value. Our valuation model uses many indicators to compare Tryp Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tryp Therapeutics competition to find correlations between indicators driving Tryp Therapeutics's intrinsic value. More Info.Tryp Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tryp Therapeutics' earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.